The findings of the present study suggest that irisin appears to be a mediator capable of promoting positive actions that are stimulated by resistance and aerobic training and related to their effects on WAT metabolism, and this can be a potential therapeutic target for treating obesity. Here, FNDC5 is linked to obesity due to melanocortin 4 receptor deficiency.